Autopsy report · NCT03941639

Using Imaging Data and Genomic Data to Predict Metastasis of Breast Cancer After Treatment

“lack a funding and withdrawal of collaborator”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 3 years 4 months before it stopped.
• 95 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Chinese University of Hong Kong

Sponsor type

University, hospital or other

Conditions

Breast Cancer

Participants

95

Sites

1

Countries

Hong Kong

Trials that died the same way

• Recovery of Upper Limb Function in Persons With Spinal Cord Injury: Lead-In Study
  “Collaborator, MyndTec, withdrew from the study due to lack of resources” (68% match in meaning)
• Multicenter Prospective Randomized Controlled Trial of Plicated Laparoscopic Adjustable Gastric Banding
  “Sponsor withdrew funding.” (68% match in meaning)
• Safety and Efficacy of ABI-009 (Nab-rapamycin) in Combination With Pomalidomide and Dexamethasone for Relapsed and Refractory Multiple Myeloma
  “Funding withdrawn by sponsor” (66% match in meaning)
• Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Tributyrin Supplementation
  “Withdrawal of funding” (65% match in meaning)
• Lucentis for New Onset Neovascular Glaucoma
  “Company withdrew funding/sponsorship” (65% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.